Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Context
Written by software from the filings listed below · Oct 13, 2026
What was filed. Catalio Capital Management, LP filed a SCHEDULE 13G on Oct 13, 2026 reporting 736,807 shares, 5.6% of the class of Fractyl Health (GUTS). SEC Schedule 13G
2 more points, with the facts they come from, are in OQRO Pro.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
“On November 2, 2026 (the “ Effective Date ”), the Board of Directors (the “ Board ”) of the Company increased the size of the Board from nine to ten and appointed Michael Wartell as a Class III director, with a term expiring at the Company’s 2027 annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier resignation or removal.”